| Identification | Back Directory | [Name]
AcetaMide, N-[2-(3,5-diMethyl-1H-pyrazol-1-yl)-6-[6-(4-Methoxy-1-piperidinyl)-2-pyridinyl]-4-pyriMidinyl]- | [CAS]
1061747-72-5 | [Synonyms]
TC-G 1004
TCG 1004,TC G 1004
N-[2-(3,5-dimethylpyrazol-1-yl)-6-[6-(4-methoxypiperidin-1-yl)pyridin-2-yl]pyrimidin-4-yl]acetamide
N-[2-(3,5-Dimethyl-1H-pyrazol-1-yl)-6-[6-(4-methoxy-1-piperidinyl)-2-pyridinyl]-4-pyrimidinyl]acetamide
AcetaMide, N-[2-(3,5-diMethyl-1H-pyrazol-1-yl)-6-[6-(4-Methoxy-1-piperidinyl)-2-pyridinyl]-4-pyriMidinyl]- | [Molecular Formula]
C22H27N7O2 | [MOL File]
1061747-72-5.mol | [Molecular Weight]
421.5 |
| Hazard Information | Back Directory | [Uses]
TC-G 1004 is a small molecule agonist of the A2A G-protein coupled receptor. | [in vivo]
TC-G 1004 (compound 16j, 3 mg/kg) displays good in vivo oral activity in rat models for Parkinson’s disease and were advanced to preclinical development[1].
TC-G 1004 (compound 16j) dose-dependently potentiates L-dopa induced rotations with an MED of 3 mg/kg when dosed orally[1].
| [storage]
Store at -20°C |
|
| Company Name: |
R&D Systems, Inc
|
| Tel: |
18003437475 18003437475 |
| Website: |
www.rndsystems.com |
|